Donatella Marino

发表论文 76 篇 · 总被引 1166 次 · h-index 16

代表论文

Tislelizumab vs Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma (2023 · JAMA Oncology · 被引 257)
Genomically matched therapy in advanced solid tumors: the randomized phase 2 ROME trial (2025 · Nature Medicine · 被引 34)
Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial (2025 · ESMO Open · 被引 18)
Clinical relevance and methodological approach for the assessment of drug–drug interactions in cancer patients: a position statement from the Italian Association of Medical Oncology (AIOM) and the Italian Society of Pharmacology (SIF) (2025 · ESMO Open · 被引 7)
The Impact of Concordance between Liquid and Tissue Biopsy for Actionable Mutations: Insights from the ROME Trial (2025 · Clinical Cancer Research · 被引 6)
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study (2025 · Liver Cancer · 被引 5)